Compare OCGN & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | CAL |
|---|---|---|
| Founded | 2013 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 400.3M |
| IPO Year | 2014 | 1994 |
| Metric | OCGN | CAL |
|---|---|---|
| Price | $2.31 | $9.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $7.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 5.1M | 468.5K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | ★ 31.58 | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $85,513,000.00 |
| Revenue This Year | N/A | $2.07 |
| Revenue Next Year | $4,139.02 | $5.65 |
| P/E Ratio | ★ N/A | $21.46 |
| Revenue Growth | N/A | ★ 0.46 |
| 52 Week Low | $0.54 | $9.32 |
| 52 Week High | $2.00 | $18.08 |
| Indicator | OCGN | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 68.81 | 28.71 |
| Support Level | $1.44 | $9.54 |
| Resistance Level | N/A | $13.55 |
| Average True Range (ATR) | 0.16 | 0.59 |
| MACD | 0.02 | -0.20 |
| Stochastic Oscillator | 85.67 | 13.10 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.